Journal of Nuclear Medicine Technology: 50 (3)

September 1, 2022; Volume 50,Issue 3

Editor's Page

You have access
Theranostics: The Future is Now!
Kathy S. Thomas

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 185;

Continuing Education

You have access
Going Nuclear with Amino Acids and Proteins: Basic Biochemistry and Molecular Biology Primer for the Technologist
Krystle Glasgow, Mike Dillard, Eric Hertenstein, Allen Justin, Remo George and Amy Brady

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 186-194; DOI: https://doi.org/10.2967/jnmt.122.263847
You have access
Practical Considerations for Implementation of ¹⁷⁷Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813
- Practical Protocol Tip
  - You have access
    ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy
    Amanda Abbott and Heather Jacene
    
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 203-204;
You have access
¹⁷⁷Lu-PSMA Therapy
Ephraim E. Parent, Bital Savir-Baruch, Isis W. Gayed, Frankis Almaguel, Bennett B. Chin, Austin R. Pantel, Evan Armstrong, Amanda Morley, Robin C. Ippisch and Robert R. Flavell

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 205-212; DOI: https://doi.org/10.2967/jnmt.122.263814
- Practical Protocol Tip
  - You have access
    ¹⁷⁷Lu-Vipivotide Tetraxetan (¹⁷⁷Lu-PSMA-617, Pluvicto) Therapy
    Sarah Clements, Daniel Tempesta and Heather Jacene
    
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 213-214; DOI: https://doi.org/10.2967/jnmt.122.264731
You have access
Nuts and Bolts of ²²³Ra-Dichloride Therapy
Erin Grady

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 215-221; DOI: https://doi.org/10.2967/jnmt.122.263812
- Practical Protocol Tip
  - You have access
    ²²³Ra-Dichloride Therapy
    Sarah Clements, Daniel Tempesta and Matthew Robertson
    
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 222-223; DOI: https://doi.org/10.2967/jnmt.122.264765

Invited Perspective

You have access
The Nuclear Medicine Technologist’s Role in Theranostics: SNMMI-TS Advocacy’s Vision
Dmitry D. Beyder, Cheryl L. Rickley, Tricia L. Peters, Jeremy L. Iman and Christina M. Arenas

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 224-227; DOI: https://doi.org/10.2967/jnmt.122.264565

Brief Communication

You have access
Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
Munish Kumar, Karthikeyan Subramanian, Karan Singh Tanwar, Arun Prabhahar, Smita Divyaveer, Ashwani Sood, Bhagwant Rai Mittal and Apurva Sood

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 228-232; DOI: https://doi.org/10.2967/jnmt.121.261979

Radionuclide Therapy

You have access
Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
Caio Vinicius Oliveira, Tatiane Sabriela Cagol Camozzato, Patricia Fernanda Dorow and Jéssica Pasqueta

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 233-239; DOI: https://doi.org/10.2967/jnmt.121.263502

Brief Communication

You have access
Indirect Lung Absorbed Dose Verification by ⁹⁰Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept
Yung Hsiang Kao, Calvin Gan, Alicia Corlett, Alexander Rhodes, Dinesh Sivaratnam and Beng Ghee Lim

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 240-243; DOI: https://doi.org/10.2967/jnmt.121.263422

Quality & Practice Management

You have access
Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical ¹⁷⁷Lu-PSMA I&T
Madhusudan Vyas, Remy Lim, Jessica Fagan and Rudresh Chandrashekar

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 244-247; DOI: https://doi.org/10.2967/jnmt.121.262423

Imaging

You have access
Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of ¹⁷⁷Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 248-255; DOI: https://doi.org/10.2967/jnmt.121.261998
You have access
Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma
Elba Etchebehere, Rebeca Andrade, Mariana Camacho, Mariana Lima, Anita Brink, Juliano Cerci, Helen Nadel, Chandrasekhar Bal, Venkatesh Rangarajan, Thomas Pfluger, Olga Kagna, Omar Alonso, Fatima K. Begum, Kahkashan Bashir Mir, Vincent Peter Magboo, Leon J. Menezes, Diana Paez and Thomas NB Pascual

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 256-262; DOI: https://doi.org/10.2967/jnmt.121.262900

Radiation Safety

You have access
Reducing Radiation Exposure from PET Patients
Shorouk F. Dannoon, Saud Alenezi, Naheel Alnafisi, Samar Almutairi, Fatma Dashti, Medhat M. Osman and Abdelhamid Elgazzar

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 263-268; DOI: https://doi.org/10.2967/jnmt.121.263223
You have access
Radiation Dose to Medical Staff from Administering ¹⁷⁷Lu-PSMA-DKFZ-617 Therapy
Elahe Mahmoudi, Elahe Pirayesh, Mohammad Reza Deevband, Mahasti Amoui, Mohammadali Ghodsi Rad, Mehrdad Ghorbani Rad and Mahdi Ghorbani

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 269-273; DOI: https://doi.org/10.2967/jnmt.121.263135

Brief Communication

You have access
Risk of Radiation Exposure to Clinical Staff from Paracenteses of Large-Volume Chylous Ascites After ¹⁷⁷Lu-DOTATATE Infusion
Sameer Tipnis, William J. Rieter, Vladimir Henderson-Suite and Leonie Gordon

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 274-277; DOI: https://doi.org/10.2967/jnmt.121.262820
You have access
⁶⁸Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141
You have access
¹⁸F-DCFPyL PET/CT in Metastatic Renal Cell Carcinoma
Geoffrey M. Currie, Marko Trifunovic, Jui Liu, Sang Kim and Howard Gurney

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 282-285; DOI: https://doi.org/10.2967/jnmt.121.262799

Teaching Case Study

You have access
PET/CT of Delayed Uterine Leiomyoma Metastasizing to Lung and Femur
Kenneth N. Huynh and Ba D. Nguyen

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 286-287; DOI: https://doi.org/10.2967/jnmt.122.263901

Departments

You have access
Message From the President
Krystle W. Glasgow

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 6A;
You have access
Technologist News
Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 8A-11A;
You have access
Information for Authors
Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 12A-17A;

Main menu

User menu

Search

Table of Contents

Editor's Page

Continuing Education

Practical Protocol Tip

Practical Protocol Tip

Practical Protocol Tip

Invited Perspective

Brief Communication

Radionuclide Therapy

Brief Communication

Quality & Practice Management

Imaging

Radiation Safety

Brief Communication

Teaching Case Study

Departments

In this issue

Issue highlights

Jump to